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Abstract
Pathogen burden is a construct developed to assess the cumulative effects of multiple, persist-
ent pathogens on morbidity and mortality. Despite the likely biological wear and tear on mul-
tiple body systems caused by persistent infections, few studies have examined the impact of
total pathogen burden on such outcomes and specifically on preclinical markers of dysfunc-
tion. Using data from two waves of the National Health and Nutrition Examination Survey, we
compared three alternative methods for measuring pathogen burden, composed of mainly
persistent viral infections, using a cumulative deficits index (CDI) as an outcome: single
pathogen associations, a pathogen burden summary score and latent class analyses. We
found significant heterogeneity in the distribution of the CDI by age, sex, race/ethnicity
and education. There was an association between pathogen burden and the CDI by all
three metrics. The latent class classification of pathogen burden showed particularly strong
associations with the CDI; these associations remained after controlling for age, sex, body
mass index, smoking, race/ethnicity and education. Our results suggest that pathogen burden
may influence early clinical indicators of poor health as measured by the CDI. Our results are
salient since we were able to detect these associations in a relatively young population. These
findings suggest that reducing pathogen burden and the specific pathogens that drive the CDI
may provide a target for preventing the early development of age-related physiological
changes.
Introduction
A growing body of research has documented the impact of persistent viral and chronic bac-
terial infections on a host of health outcomes, including cardiovascular disease [1, 2] and cog-
nitive impairment [3] as well as markers of cellular aging such as telomere length [4].
Persistent infections may operate through several biological mechanisms such as tissue dam-
age, localised inflammation and/or cellular processes [5]. Of particular interest are the chronic
effects of the reactivation of latent infections over the life course which cause the release of
pro-inflammatory cytokines, such as interleukin-6 and acute-phase, C-reactive protein
(CRP) both of which have been implicated in many of the hallmark diseases of aging.
These infections likely result in biological dysfunction across multiple body systems, beginning
early in the life course before clinical deficits are manifest by traditional biomarker assessment
[6]. Thus, using a clinical laboratory value-based deficits index that detects those at the higher
(or lower) end of the normal range may highlight individuals on a trajectory for the develop-
ment of multiple, chronic conditions.
Given the increasing numbers of chronic diseases with an infectious etiology, understand-
ing the biological consequences of persistent infection is of critical importance. Pathogen bur-
den, or infection burden, is a construct developed to assess the cumulative effects of multiple,
persistent pathogens on morbidity and mortality [7]. Pathogen burden has been measured in
several different ways [1, 8–13]. Some studies have focused on single pathogen associations
examining the impact of each individual infection on a distal health outcome. Other studies
have examined pathogen burden as a summary index of all pathogens for which an individual
is seropositive. In 2015, Simanek et al. conducted a study that demonstrated the need to go
beyond the ‘black box’ of pathogen burden, by incorporating both the number of pathogens
and the specific combinations of different pathogens that may influence health [8].
Few studies have explicitly examined the impact of the pathogen on a cumulative deficits
index (CDI) among individuals in young and mid-adulthood. Using data from two waves
of the National Health and Nutrition Examination Survey (NHANES), we compared three
alternative methods for measuring pathogen burden using a laboratory-based CDI as an out-
come [14]. The CDI offers a way to quantify multi-system biological dysfunction before
by King et al. [15] and others examining laboratory indices of
frailty [14, 16]. Twenty-eight biomarkers were incorporated in
the CDI such as albumin levels, white blood cell count, calcium
levels and cholesterol. Table 1 describes each of the 28 biomarkers
utilised in the CDI along with their corresponding body system/
process and the cut-points utilised. King et al. used cut-points
based on clinical significance in older adults. Given the young
age of our study sample, many are not likely showing abnormal
values for the biomarkers assessed. Thus, we utilised an approach
aimed at ascertaining those at the higher/lower end of the normal
range depending on the specific biomarker. This determination
was made for each biomarker depending on the direction indicat-
ing dysfunction. Each biomarker was split into quartiles and those
in the highest (or lowest) quartile of the distribution received a
score of 1. For some biomarkers, both high and low values can
indicate dysfunction. For those markers, the distribution was
split into eighths and both the top eighth and bottom eighth
received a score of 1. This approach has been used in other bio-
marker studies [17]. The final CDI was constructed by summing
the number of biomarkers for which an individual received a
score of 1 divided by the total number of biomarkers available
for that individual. We then examined the distribution of the
CDI in the population as a whole and then by age, gender,
race/ethnicity, education, smoking behavior and body mass
index (BMI).
Covariates
We included covariates in our regression analyses that are well
established in the literature as relating to pathogen burden and/
or the CDI. These covariates included basic demographic infor-
mation as well as health characteristics.
Basic demographic variables included age, sex, race/ethnicity
and education. Age was analysed as a continuous variable in
years. Sex was binary coded as male or female. Race/ethnicity
was categorised according to the NHANES guidelines as non-
Hispanic White, non-Hispanic Black, Mexican American, other
Hispanic and other race. Education was treated categorically
according to NHANES classifications as less than a high school
education, high school graduate, some college education and col-
lege graduate and above.
Health status characteristics included BMI and smoking status.
BMI was examined categorically with those with a BMI less than
18.5 classified as underweight; 18.5–25 classified as normal; 25–30
classified as overweight and greater than 30 classified as obese.




Linear regression models were constructed to investigate the asso-
ciation between each individual pathogen and the CDI. We esti-
mated the mean difference and 95% confidence interval (CI)
for those with- and without infection.
Pathogen burden summary score
We investigated the association between the pathogen burden
summary score in two different ways. First, we examined the asso-
ciation between the continuous pathogen burden summary score
and the CDI using linear regression models. The incremental
increase in the CDI and 95% CI were calculated for each one-unit
increase in the pathogen summary score. We then split the
clinical disease is apparent [15]. We hypothesised that latent class 
methods that incorporate both the number and combination of 
pathogens would show the most robust relationship between 
pathogen burden and the CDI.
Methods
Study sample
We used two waves of the continuous NHANES collected by the 
National Center for Health Statistics. NHANES is a cross-
sectional, nationally representative survey of the health and nutri-
tional status of the US non-institutionalised, civilian population 
aged 2 months and older. Our study population was drawn 
from the 2003–2004 and 2009–2010 waves. Details of the sam-
pling strategy for the continuous NHANES can be found at: 
https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx.
For each of the NHANES 2003–2004 and 2009–2010 waves, 
individuals provided information on a range of demographic 
characteristics based on the in-home interview. A subset of indi-
viduals also participated in the physical examinations and labora-
tory studies performed at the mobile examination center. We 
selected two waves so as to replicate the findings across samples 
and with slightly different combinations of pathogens. The 
2003–2004 and 2009–2010 waves were preferable due to the 
quantity and types of pathogens tested in these waves. We did 
not use a combined study sample because we were also interested 
in testing the association of individual pathogens (not all of which 
were the same in each wave) with the CDI.
Our study sample included 20–49 years old who participated 
in the survey, physical examination and laboratory studies 
(Supplementary Fig. 1). The study sample included pregnant 
women, confirmed either by self-report or laboratory testing. 
There were 14 623 participants in the 2003–2004 wave and 10 
846 in the 2009–2010 wave. Of those, 4980 participants were 
excluded because they did not participate in the interview, phys-
ical examination and laboratory studies in the 2003–2004 wave; 
560 in the 2009–2010 wave. An additional 6934 individuals 
were excluded for whom there was not complete pathogen sample 
information available in the 2003–2004 wave; 8043 in the 2009–
2010 wave. The final sample included only those with complete 
covariate information (2003–2004 Wave Final N = 2168; 2009–
2010 Wave Final N = 2546).
This study was approved by the Campus Institutional Review 
Board of Duke University.
Laboratory analyses
Laboratory information used to construct the CDI was based on 
the biomarkers assessed from blood serum collected as part of 
the standard biochemistry profile of the NHANES laboratory 
examination. Additional information on specimen collection can 
be found in the NHANES Laboratory/Medical Technologists 
Procedures Manual. The specific biomarkers included in the CDI 
are shown in Table 1. The pathogen measurement information is 
included in the Supplementary files.
Measures
The pathogen burden summary score was created by summing 
the number of pathogens for which an individual was seroposi-
tive. The construction of the CDI followed a methodology utilised
pathogen burden summary score into categories: 0–1 pathogens, 2
pathogens, 3 pathogens, and 4+ pathogens. Using linear regres-
sion models, we then examined the mean difference in the CDI
using 0–1 pathogens as the referent.
Latent class analyses
To further characterise pathogen burden, we performed latent
class analyses on each wave of data. This method assigns indivi-
duals with similar profiles to mutually exclusive classes using
both manifest (measured) and latent (unmeasured) characteris-
tics. We followed a three-step inclusive classify-analyse approach
developed by Bray et al. [18]. This approach separates the classi-
fication of individuals into latent classes from the regression of the
outcome on the latent classes.
In the first phase, we determined the appropriate number of
latent classes for each wave by comparing a series of model fit
indices: the likelihood-ratio value (G2), Akaike information criteria
(AIC), Bayesian information criterion (BIC), sample size-adjusted
BIC, log-likelihood and entropy. Lower values for the AIC, BIC,
adjusted AIC are preferred as they indicate better model fit.
Higher values of entropy indicate the greater distinction between
the classes. When deciding on the optimal number of classes, we
prioritised both model fit and interpretability of the classes.
Model estimation was repeated 1000 times with random starts to
confirm model identification. Latent class models were estimated
using PROC LCA SAS Version 9.4.
Once the appropriate number of latent classes was determined,
we assigned individuals to a specific latent class based on their
posterior probability of most likely class membership. Following
the inclusive classify-analyse approach, the outcome variable,
the CDI, was used as a covariate in the final model to reduce
bias in estimation in the outcome model [18].
Table 1. Biomarkers included in the laboratory-based cumulative deficits index based on the National Health and Nutrition Examination Survey
Biomarker Body system/Process Early dyfunction cutpointsa % Early dysfunction
Albumin (μg/ml) Liver, nutrition ⩽4.0 28.1
AST (units/l) ⩾27.0 27.7
Calcium (mg/dl) Bone, nutrition ⩽9.1; ⩾9.9 30.5
Creatinine (mg/dl) Kidney ⩾1.0 27.5
Glucose (mg/dl) Pancreas ⩾94 25.9
Heamoglobin (g/dl) Bone marrow M: ⩽14.9; F: ⩽12.6 26.6
Alkaline phosphatase (units/l) Liver, biliary tract ⩾79.0 25.9
Phosphorus (mg/dl) ⩽3.2; ⩾4.5 26.1
Potassium (mmol/l) Kidney, endocrine ⩽3.6; ⩾4.3 29.4
Total protein (g/dl) Nurition, inflammation & myeloma ⩾7.6 25.5
Sodium (mmol/l) Kidney, liver, heart ⩽137; ⩾141 22.1
BUN (mg/dl) Kidney ⩾13 27.2
White blood cell count (1000 cells/μl) Inflammation ⩾8.9 25.9
Platelet count (1000 cells/μl) Inflammation ⩽201; ⩾345 25.4
Segmented neutrophils number ⩾5.6 25.9
Cholesterol (mg/dl) Liver, heart risk ⩾225 25.1
HDL (mg/dl) Heart risk M: ⩽40; F: ⩽47 26.9
Uric acid (mg/dl) Joints, kidney M: ⩽6.7; F: ⩽5.0 27.7
Chloride (mmol/l) Metabolism, kidney ⩽101; ⩾106 37.7
Lactic dehydrogenase (units/l) Liver, malignancy ⩾135 25.6
GGT (units/l) Liver ⩾29 25.4
Bilirubin (mg/dl) Biliary tract, gall bladder ⩾0.90 29.0
Triglycerides (mg/dl) Metabolism, heart risk ⩾155 25.1
Globulins (g/dl) Inflammation ⩾3.3 26.9
SGPT (units/l) (ALT) Liver ⩾31 25.1
Bicarbonate (milli-EQ/l) Metabolism, liver, kidney ⩽22; ⩾27 20.6
C-Reactive Protein Inflammation ⩾0.49 25.3
Iron (μg/dl) ⩽46; ⩾129 25.7
M, male; F, female.
aEarly dysfunction based on below or above the quartile cutpoint.
Results based on 2003–2004 wave; process was replicated in subsequent waves.
Statistical analyses were performed in SAS v.9.4 (Cary, NC).
Results
Sample characteristics
Wave 1 (2003–2004) consisted of 2168 individuals (Table 2). The
mean age was 34.9 years and the sample was 69% non-Hispanic
White. One-quarter of participants had a college education or
above. Over half (52%) of the sample reported no smoking his-
tory. Moreover, a majority of the sample was classified as over-
weight or obese (64%). Wave 2 (2009–2010) consisted of 2546
individuals. The mean age was 34.7 years and the sample was
62% non-Hispanic White. In wave 2, 28% of participants had a
college education or above. Again, over half the sample (58%)
reported no smoking history and a majority were overweight or
obese (66%).
In wave 1, we examined the proportion of the population that
was seropositive to seven pathogens. Of the wave 1 sample, 60%
were seropositive to HSV-1; 19% to HSV-2; 25% to HPV; 13%
to toxoplasmosis; 52% to CMV; 0.44% to HIV; and 2% to syphilis.
In wave 2, we examined the proportion of the study population
seropositive to five pathogens. Of the wave 2 sample, 57% were
seropositive to HSV-1; 15% to HSV-2; 34% to HPV; 12% to toxo-
plasmosis; and 0.37% to HIV. Pathogen correlations are given in
Supplementary Table 1.
Cumulative deficits index
In wave 1, the CDI ranged from 0.04 to 0.78 with a mean of 0.30
(standard error of the mean = 0.003) (Table 3, Supplementary
Fig. 2a). Increasing age was associated with an increase of 0.002
in the CDI (P < 0.001). There were also significant differences in
the CDI by sex, race/ethnicity, education, smoking status and
BMI.
In wave 2, the CDI ranged from 0 to 0.74 with a mean of 0.27
(standard error of the mean = 0.004) (Table 3, Supplementary
Fig. 2b). Similar trends were observed in the wave 2 study popu-
lation for race/ethnicity, education, smoking status and BMI.
Latent class assignment of pathogen burden
Model fit statistics were assessed for latent class models with one
to six latent classes. Based on both model fit indices and
interpretability, a three-class solution seemed best for both
waves 1 and 2 as it optimised BIC, adjusted BIC and entropy,
with near optimal levels of AIC (Supplementary Tables 2a and b).
Figures 1a and b show the conditional probabilities of pathogen
positivity for each latent class. For each wave, one class of individuals
had lower probabilities of being positive on all pathogens, the ‘low
burden’ class. Similarly, for each wave one class of individuals had
higher probabilities of being positive on several of the pathogens
tested, the ‘high burden’ class. Finally, each wave had a significant
Table 2. Population-weighted demographic and pathogen characteristics of the
study population in the National Health and Nutrition Examination Survey,
2003–2004 and 2009–2010
Wave 1 Wave 2
2003–2004 2009–2010
(N = 2168) (N = 2546)
Age
Mean age (S.D.) 34.9 (0.30) 34.7 (0.21)
N (%) N (%)
Sex
Female 1130 (50) 1365 (52)
Race/Ethnicity
Non-Hispanic White 1045 (69) 1127 (62)
Non-Hispanic Black 500 (12) 427 (12)
Mexican American 471 (10) 538 (12)
Other Hispanic 82 (4) 299 (7)
Other race 70 (4) 155 (7)
Education
Less than high school 484 (15) 655 (18)
High school graduate 569 (27) 588 (22)
Some college 676 (34) 772 (32)
College graduate and above 439 (25) 531 (28)
Ever smoker
Yes 975 (48) 1073 (42)
No 1193 (52) 1473 (58)
Body Mass Index (BMI)
Under weight (<18.5) 41 (2) 43 (2)
Normal (⩾18.5; <25) 703 (34) 772 (32)
Overweight (⩾25, <30) 709 (33) 788 (31)
Obese (⩾30) 715 (31) 943 (35)
Pathogens seropositivity
Herpes simplex virus Type 1 1397 (60) 1637 (57)
Herpes simplex virus Type 2 472 (19) 566 (15)
Human papolomavirus 542 (25) 945 (34)
Toxoplasmosis 296 (13) 372 (12)
Human immunodeficiency virus 13 (0.44) 14 (0.37)
Cytomegalovirus 1315 (52) NM
Syphillis 51 (2) NM
NM, not measured.
Regression analyses
Using the three methods of classifying pathogen burden (single 
pathogen association, pathogen burden summary score and latent 
class analysis), we constructed a series of linear regression models 
to examine the association with each measure of pathogen burden 
and the CDI. For each method of pathogen burden, model 1 
shows the association without any control variables (i.e. 
unadjusted model); model 2 shows the association with base con-
trols (i.e. age, sex, BMI and smoking status); model 3 shows the 
association with base controls and race/ethnicity status; model 4 
shows the association with base controls and education; and 
model 5 is the full model with base controls, race/ethnicity and 
education. These models were replicated using wave 1 and wave 
2 study samples.
All regression analyses used appropriate sampling weights and 
adjustments to account for the complex survey design features. A 
two-side alpha of 0.05 was used to determine significance in all 
statistical analyses.
portion of individuals who were positive for common pathogens
such as CMV and HSV-1, the ‘common pathogens’ class. For stat-
istical modeling, the low burden class was used as the referent.
For wave 1, 50% of participants were assigned to the low bur-
den class; 37% to the common pathogens class; and 13% to the
high burden class. For the wave 2 sample, 37% of the participants
were assigned to the low burden class; 46% to the common patho-
gens class; and 17% to the high burden class.
Regression results
Single pathogen associations
In wave 1 unadjusted single pathogen models, we observed a sig-
nificant relationship between CMV, HSV-1, HPV, Toxoplasmosis,
HIV and the CDI (Table 4). With the exception of HPV, infection
with a pathogen resulted in a greater mean CDI compared with
no infection. However, in the full model (model 5) only HIV
remained significantly associated with the CDI. Individuals
with HIV had a mean CDI 0.11 higher than those without HIV
(P < 0.05).
In wave 2, a similar pattern was observed with the exception of
HPV. In the full model (model 5), both HPV and HIV were sig-
nificantly associated with the CDI. Individuals with HPV had a
mean CDI 0.01 higher than those without HPV (P < 0.05).
Those with HIV had a mean CDI 0.12 higher than those without
HIV (P < 0.01).
Pathogen summary score
A significant relationship was observed between the pathogen
summary score and the CDI in models 1–4 in wave 1.
However, in the full model (model 5) this relationship was null
(P = 0.11). Similarly, when the pathogen summary score was
split into categories, there were no significant relationships
observed in the full model.
While a significant relationship between the pathogen sum-
mary score and the CDI appeared in models 1–4 in wave 2, in
Table 3. The descriptive statistics of the cumulative deficits index and the distribution of the cumulative deficits index by key demographic characteristics in the
National Health and Nutrition Examination Survey, 2003–2004 and 2009–2010.
Wave 1 Wave 2
2003–2004 2009–2010
N = 2168 N = 2546
Mean cumulative deficits index 0.30 0.27
Mean P Mean P
Age (year) 0.0017 <0.001 0.0025 <0.001
Gender
Male Ref Ref.
Female −0.075 <0.001 −0.068 <0.001
Race/Ethnicity
Non-Hispanic White Ref Ref.
Non-Hispanic Black 0.027 <0.001 0.035 0.001
Mexican American 0.04 <0.001 0.031 <0.05
Other Hispanic 0.045 0.01 0.024 0.06
Other race 0.025 0.05 0.0004 0.97
Education
College grad and above Ref. Ref.
Some college 0.021 <0.01 0.036 <0.001
High school graduate 0.035 <0.001 0.045 <0.001
Less than high school 0.048 <0.001 0.06 <0.001
Ever smoker
No Ref. Ref.
Yes 0.021 <0.01 0.013 <0.05
Body Mass Index (BMI)
Under weight (less than 18.5) −0.010 0.54 0.011 0.41
Normal (⩾18.5; <25) Ref. Ref.
Overweight (⩾25, <30) 0.054 <0.001 0.045 <0.001
Obese (⩾30) 0.1 <0.001 0.11 <0.001
Results based on linear regression models; P values reflect a two-sided test.
the full model this relationship was null (P = 0.06). However, when
the pathogen summary score was split into categories, a significant
relationship across models was observed between individuals hav-
ing four or more pathogens compared with those having 0–1
pathogens. Those having four or more pathogens had a mean
CDI 0.06 higher than those having only 0–1 pathogens (P < 0.001).
Latent class analyses
A significant relationship between latent classes of pathogen bur-
den and the CDI was observed across all models in wave 1. In the
full model (model 5), those in the high burden class had a mean
CDI 0.03 higher than those in the low burden class (P < 0.001).
Those in the common pathogens class had a mean CDI 0.04
higher than those in the low burden class (P < 0.001).
Similarly, in wave 2 there was a significant relationship
between those in the high burden class and those in the low bur-
den class with the CDI across models. In model 5, those in the
high burden class had a mean CDI 0.02 greater than those in
the low burden class (P < 0.05).
Sensitivity analyses
The finding in the single pathogen analysis in wave 1 that infec-
tion with HPV and syphilis both resulted in a lower mean CDI
did not follow our hypothesised direction. We performed sensitiv-
ity analyses in which we removed HPV and syphilis from the
pathogen summary score. We found modest changes in the asso-
ciation between the pathogen summary score and the CDI; how-
ever, the precision of the estimates did increase (Supplementary
Table 3).
We also performed additional analyses excluding HIV from
the pathogen burden summary score. While there was a modest
attenuation in the effect size across models, the inferences regard-
ing the associations were unchanged. In the full model (model 5),
there remained a null relationship between the pathogen burden
summary score and the CDI (results not shown).
We ran sensitivity analyses controlling for self-reported
chronic conditions. Nearly a quarter (21%) of the study sample
had one or more self-reported chronic health conditions. When
we controlled for this in the analyses, we found no substantive
changes in the effect estimates or the inferences. These results
lend further support to the CDI as a preclinical marker of bio-
logical dysfunction. We also tested whether excluding pregnant
women would change the association between the infections
and the CDI. Excluding pregnant did not result in a substantial
change in either the effect estimates or the inferences.
Discussion
We used a cumulative deficits approach to examine the impact of
total pathogen burden on biological functioning in a nationally
representative sample of individuals aged 20–49 years. We
found significant heterogeneity in the distribution of the CDI
by age, sex, race/ethnicity and education suggesting that it may
indeed be detecting underlying disparities in biological dysfunc-
tion, even in a middle-aged sample (aged 20–49 years). While
other studies have demonstrated the impact of persistent infec-
tions on morbidity and mortality later in the life course, our find-
ings demonstrate the impact of these infections on biological
function before clinical disease typically manifests. We also com-
pared several methods of assessing pathogen burden and their
associations with the CDI. Our results suggest that the CDI
may be a useful way to assess the impact of pathogen burden.
Latent class analyses, in particular, may be advantageous for char-
acterising pathogen burden as they can account for both the num-
ber and combinations of pathogen burden, as well as detect and
adjust for unobserved heterogeneity in the population.
Detecting biological wear and tear before clinical dysfunction
is critical to understanding patterns of morbidity and mortality
throughout the life course and particularly how they relate to
the aging process. Many of the hallmark diseases of aging begin
with physiological changes earlier in the life course [19]. A grow-
ing body of work is examining biomarkers of aging [20] in
younger cohorts as a way to pinpoint when in the life course
these changes happen as well as to design interventions that
may slow the aging process in younger individuals. The CDI we
employed can be conceptualised as a manifestation of the health
status of multiple body systems. Since our population spanned
young adulthood to middle age, our aim in the use of the CDI
was to detect individuals at pre-dysfunction levels, on a trajectory
towards the development of multiple clinical deficits. The signifi-
cant variation we observed by age, gender, race/ethnicity, educa-
tion, smoking status and BMI suggest that CDI may be useful
in detecting pre-dysfunction in a younger cohort. Additionally,
the social disparities by race/ethnicity and education suggest
that the CDI may be another method for examining the origins
of health disparities. Current work is under way to further inves-
tigate these social disparities.
An increasing number of age-related processes and chronic
diseases have been shown to have an infectious aetiology [21,
22]. Persistent infections are often subclinical and may not
cause severe illness at the time of infection [23–25] but the
Fig. 1. (a) The conditional probability of each infection given a three class solution
for the National Health and Examination Survey, 2003–2004 wave (N = 2168). (b)
The conditional probability of each infection given a three class solution for the
National Health and Examination Survey, 2009–2010 wave (N = 2546).
. https://doi.org/10.1017/S095026881800153X
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Table 4. Results of the regression analysis examining the association between measures of pathogen burden and the cumulative deficits index in the National









Base + Education Model 5: Full
Single pathogen
association Coeff P Coeff P Coeff P Coeff P Coeff P
Wave 1: N = 2168
CMV 0.01 <0.05 0.02 <0.001 0.01 0.09 0.02 <0.01 0.01 0.15
HSV-1 0.02 <0.01 0.01 0.05 0.01 0.27 0.01 0.16 0.01 0.42
HSV-2 0.01 0.15 0.01 0.08 0.01 0.39 0.01 0.19 0.00 0.47
HPV −0.02 <0.01 −0.01 0.21 −0.01 0.25 −0.01 0.22 −0.01 0.24
Syphilis −0.02 0.58 −0.01 0.63 −0.02 0.41 −0.02 0.48 −0.02 0.36
Toxoplasmosis 0.02 <0.05 0.01 0.05 0.01 0.29 0.01 0.12 0.01 0.36
HIV 0.12 <0.01 0.12 <0.01 0.11 <0.05 0.11 <0.01 0.11 <0.05
Pathogen summary score
Continuous 0.01 <0.01 0.01 0.00 0.004 0.04 0.01 <0.01 0.003 0.11
Categories
0–1 Pathogens Ref. Ref. Ref. Ref. Ref.
2 Pathogens 0.01 0.46 0.01 0.28 0.00 0.97 0.01 0.53 −0.001 0.89
3 Pathogens 0.01 0.28 0.02 <0.05 0.01 0.44 0.01 0.11 0.004 0.58
4+ Pathogens 0.01 0.23 0.02 <0.05 0.01 0.34 0.02 0.12 0.01 0.58
Latent class analysis
‘Low burden’
‘Common pathogens’ 0.05 <0.001 0.05 <0.001 0.04 <0.001 0.04 <0.001 0.04 <0.001
‘High Burden’ class 0.04 <0.001 0.04 <0.001 0.03 <0.001 0.04 <0.001 0.03 <0.001
Wave 2: N = 2246
HSV-1 0.02 <0.01 0.02 <0.05 0.01 0.07 0.01 0.17 0.01 0.29
HSV-2 0.02 <0.01 0.02 <0.05 0.01 0.20 0.01 0.19 0.004 0.55
HPV −0.01 <0.05 0.01 <0.01 0.01 <0.05 0.01 <0.05 0.01 <0.05
Toxoplasmosis 0.03 <0.01 0.01 0.220 0.005 0.49 0.00 0.73 0.00 0.93
HIV 0.16 <0.001 0.13 <0.01 0.12 <0.01 0.13 <0.01 0.12 <0.01
Pathogen summary score
Continuous 0.01 <0.001 0.01 <0.001 0.01 <0.01 0.01 <0.05 0.01 0.06
Categories
0–1 Pathogens Ref. Ref. Ref. Ref. Ref.
2 Pathogens 0.01 <0.05 0.02 <0.05 0.01 0.07 0.01 0.16 0.01 0.28
3 Pathogens 0.02 <0.05 0.02 <0.05 0.02 <0.05 0.01 0.06 0.01 0.15
4+ Pathogens 0.08 <0.001 0.08 <0.001 0.07 <0.001 0.06 <0.001 0.06 <0.001
Latent class analysis
Low burden
‘Common pathogens’ 0.02 <0.01 0.02 <0.01 0.01 <0.05 0.01 0.110 0.01 0.18
‘High burden’ class 0.04 <0.001 0.03 <0.001 0.03 <0.01 0.02 <0.01 0.02 <0.05
Coeff, coefficient; P, P-value.
Results are based on linear regression models using complex survey weights.
Significant results at α = 0.05 are bolded.
latent class analysis is detecting. Future studies would benefit
from a more explicit examination of socioeconomic status and
other social/behavioral indicators and how they affect exposure
and infection with pathogens.
Our study has several limitations. First, this is a cross-sectional
analysis thus precluding any causal inferences regarding pathogen
burden and the CDI. Future studies should investigate whether
pathogen burden is predictive of changes in the CDI over time.
Nonetheless, most of the infections of interest are transmitted
in early childhood or adolescence while the CDI includes pre-
dominantly measures that emerge in later life, strengthening
the likelihood that infection temporally precedes the CDI.
As discussed above, the results of this study suggest an under-
lying social structuring of the distribution of pathogens. We were
limited by data availability on social variables in NHANES.
Replication of this study with datasets that offer a more robust
measurement of the social environment could shed further light
on the social processes at work.
Our measurement of pathogen burden was limited by the
pathogens tested in NHANES. There are likely other infections
that may be important predictors of physiological dysfunction
that we were not able to examine because they were not tested
in NHANES. Moreover, the NHANES reports only seropositivity
and not circulating antibody levels of infection. There is research
to suggest that antibody levels may indicate the severity of infec-
tion [38, 39] and thus is a stronger measure of infection rather
than simply seropositivity. Future studies should investigate
whether antibody levels of infections are associated with early
markers of dysfunction.
Finally, while the CDI is useful in detecting global dysfunction,
it is not specific to a single physiological process. Follow-up stud-
ies should further interrogate specific pathophysiological path-
ways linking chronic infection to biological dysfunction.
In conclusion, our results suggest that pathogen burden may
influence early clinical indicators of poor health as measured by
the CDI. Our results are salient because we were able to detect
associations between pathogen burden and CDI in a relatively
young population, where the onset of the disease is rarer but
represents a period in which interventions targeting pathogen
burden may help offset early changes in CDI and ultimately dis-
ease risk. These findings suggest that reducing overall pathogen
burden and particularly the specific pathogens that drive the
CDI, may provide a target for preventing the early development
of age-related physiological changes.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S095026881800153X.
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chronic reactivation of these infections across the life course can 
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in this area focused on understanding the link between persistent 
infections and cardiovascular disease, specifically atherosclerosis 
[7, 26–29]. Studies of CMV specifically have found links with 
not only cardiovascular mortality [30] but incident depression 
[31] and frailty in older adults [32]. Current work has extended 
this body of research to include understanding the underlying 
distribution of these infections along lines of social disadvantage 
[1, 12, 33, 34].
Recently research in this area has begun to examine the effects 
of pathogen burden on markers of biological aging. Dowd et al. 
reported that infection with several herpesvirus coinfections 
resulted in substantial declines in leukocyte telomere length 
over a 3-year period [4]. The magnitude of the association 
reported was suggestive of substantial accelerated biological 
aging resultant from pathogen burden. Previous studies using a 
cumulative deficits approach to examine frailty have reported 
consistent relationships with mortality [35, 36] and have proposed 
that such indices may proxy biological age [36]. While we could 
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measurement techniques need to account for both the number of 
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Our results suggest latent class analyses may be advantageous 
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class methods is that they account for unobserved heterogeneity 
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distribution and covariance of different variables, latent class 
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cumulative immune response class, a moderate immune response 
class and a high immune response class with elevated antibody 
levels for each of the four pathogens examined [10].
Our findings suggest that in the case of characterising pathogen 
burden the latent class method is advantageous for detecting and 
adjusting for unobserved heterogeneity in clusters of individuals 
with similar pathogen profiles. In this study, the latent construct 
may be best described as a means of sorting individuals based 
both on their likelihood of exposure to pathogens as well as on 
their susceptibility to infection once exposed to a pathogen. The 
high burden group may then be conceptualised as those most vulner-
able to infection in the study population: more likely to be exposed to 
pathogens and more susceptible to infection once exposed.
The attenuation of the associations in the single pathogen 
associations and pathogen summary score when race/ethnicity 
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